Chino Hills, CA, United States of America

Negemias T Alido

This inventor holds 1 USPTO granted patent. Top assignee: Vivorx Autoimmune, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Negemias T Alido. Retrieved from https://idiyas.com/inventor/negemias-t-alido

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Negemias T Alido

Introduction

Negemias T Alido is a notable inventor based in Chino Hills, California. He has made significant contributions to the field of autoimmune research, particularly in relation to systemic lupus erythematosus. His work has led to the identification of important autoantigens that play a role in this complex disease.

Latest Patents

Negemias T Alido holds a patent for the HP-8 autoantigen. This autoantigen is associated with systemic lupus erythematosus and is expressed by a gene identified through immunoscreening of a human placental cDNA GT11 expression library. The monoclonal antibody 3E10, which is a low-affinity anti-double-stranded DNA autoantibody derived from MRL murine models, is crucial in this research.

Career Highlights

Negemias T Alido is currently affiliated with Vivorx Autoimmune, Inc., where he continues to advance his research in autoimmune diseases. His work has been instrumental in understanding the mechanisms underlying systemic lupus erythematosus, contributing to potential therapeutic approaches.

Collaborations

He has collaborated with notable colleagues, including Cynthia K French and Karen K Yamamoto, who share his commitment to advancing research in autoimmune disorders.

Conclusion

Negemias T Alido's innovative work in identifying the HP-8 autoantigen marks a significant advancement in the understanding of systemic lupus erythematosus. His contributions continue to influence the field of autoimmune research and hold promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…